| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |